An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.

Market Analysis and Insights: Global Medical Insulin Pumps Market
In 2020, the global Medical Insulin Pumps market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Medical Insulin Pumps Scope and Market Size
The global Medical Insulin Pumps market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Insulin Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Patch Pump
Normal Pump

Segment by Application
Type I Diabetes
Type II Diabetes

By Company
Medtronic
Roche
Johnson & Johnson
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL Development
Microport
Biotech SA
Valeritas Holdings
Ypsomed Holding AG

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE